| Financial Year |
March 31 2023 |
| Monetary Funds |
169,764,210.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
406,929,205.86 |
| Advances to Suppliers |
1,011,548.18 |
| Other Receivables |
17,593,819.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
41,397,653.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
5,500,000.00 |
| Other Current Assets |
952,511.87 |
| Total Current Assets |
645,290,988.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
108,495,870.74 |
| Fixed Assetes |
23,292,146.29 |
| Under-construction Projects |
259,705.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
123,198,073.89 |
| R&D expenses |
-- |
| Goodwill |
1,048,552.46 |
| Long-Term Deferred and Prepaid Expenses |
1,883,342.82 |
| Deferred Income Tax Assets |
12,772,930.45 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
299,904,910.15 |
| Total Assets |
945,195,899.04 |
| Short-Term Loans |
98,129,204.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
85,395,118.90 |
| Accounts Received In Advance |
2,128,188.20 |
| Employee Compensation Payable |
18,508,110.26 |
| Taxes Payable |
25,755,219.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,300,516.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
680,563.33 |
| Sub-Total of Current Liabilities |
273,498,599.06 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
-- |
| Total Liabilities |
273,498,599.06 |
| Paid-In Capital(Or Share Stock) |
503,650,562.00 |
| Capital Surplus |
307,093,919.20 |
| Surplus Reserve |
9,287,164.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-141,830,385.41 |
| Minority Stockholder's Interest |
-251,664.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
671,948,964.89 |
| Owner's Equity（Stockholder's Equity） |
671,697,299.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
945,195,899.04 |
